GENRX LINEZOLID linezolid 600 mg tablet blister pack

Country: Ավստրալիա

language: անգլերեն

source: Department of Health (Therapeutic Goods Administration)

active_ingredient:

linezolid, Quantity: 600 mg

MAH:

Arrotex Pharmaceuticals Pty Ltd

INN:

Linezolid

pharmaceutical_form:

Tablet, film coated

composition:

Excipient Ingredients: magnesium stearate; hypromellose; macrogol 8000; crospovidone; methylcellulose; titanium dioxide; hyprolose; silicon dioxide

administration_route:

Oral

units_in_package:

10

prescription_type:

(S4) Prescription Only Medicine

therapeutic_indication:

Linezolid (intravenous or oral) is indicated for the treatment of suspected or proven infections due to Gram positive organisms resistant to multiple classes of antibiotics, including methicillin resistant Staphylococcus species and vancomycin resistant Enterococcus species. It is active against Gram-positive bacteria only and has no clinical activity against Gram-negative pathogens. Specific Gram-negative therapy is required if a concomitant Gram-negative pathogen is documented or suspected.

leaflet_short:

Visual Identification: White coloured, oval shaped, biconvex, film-coated tablet with "APO" engraved on one side and "LIN600" on the other side.; Container Type: Blister Pack; Container Material: PVC/Al; Container Life Time: 24 Months; Container Temperature: Store below 30 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

authorization_status:

Licence status A

authorization_date:

2014-01-31